Channel Wealth’s AbbVie ABBV Stock Holding History

Channel Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$730K	Sell	2,902 -3	-0.1%	-$645	0.16%	87
2026 Q1	$632K	Sell	2,905 -247	-8%	-$54.8K	0.15%	89
2025 Q4	$720K	Buy	3,152 +244	+8%	+$55.6K	0.18%	77
2025 Q3	$673K	Sell	2,908 -204	-7%	-$41.5K	0.18%	83
2025 Q2	$578K	Buy	3,112 +133	+4%	+$24.7K	0.16%	86
2025 Q1	$624K	Sell	2,979 -6,449	-68%	-$1.25M	0.19%	86
2024 Q4	$1.68M	Buy	9,428 +4,398	+87%	+$809K	0.55%	53
2024 Q3	$993K	Sell	5,030 -14,734	-75%	-$2.75M	0.33%	60
2024 Q2	$3.39M	Buy	19,764 +4,830	+32%	+$800K	1.23%	24
2024 Q1	$2.72M	Sell	14,934 -3,380	-18%	-$583K	1.09%	31
2023 Q4	$2.84M	Buy	18,314 +2,176	+13%	+$317K	1.34%	26
2023 Q3	$2.41M	Buy	16,138 +2,347	+17%	+$345K	1.35%	19
2023 Q2	$1.86M	Buy	13,791 +4,787	+53%	+$702K	1.07%	22
2023 Q1	$1.43M	Buy	+9,004	New	+$1.38M	0.92%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Channel Wealth's ABBV Position: Q2 2026 in Review

Channel Wealth reduced its AbbVie (ABBV) stake by 0.1% in Q2 2026, selling an estimated $645 and leaving 2,902 shares worth $730K. The position accounts for 0.16% of the portfolio, ranked #87.

Channel Wealth first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.39M in Q2 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Channel Wealth held 2,902 shares of AbbVie worth $730K as of Q2 2026.
Channel Wealth sold 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.16% of Channel Wealth's portfolio in Q2 2026, its #87 holding.
Channel Wealth first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
Channel Wealth's AbbVie position peaked at $3.39M in Q2 2024.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Channel Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.